These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31517021)

  • 21. Acute effects of snus in never-tobacco users: a pilot study.
    Ozga JE; Felicione NJ; Elswick D; Blank MD
    Am J Drug Alcohol Abuse; 2018; 44(1):113-119. PubMed ID: 27929684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral Nicotine Product Awareness and Use Among People Who Smoke and Vape in the U.S.
    Felicione NJ; Schneller LM; Goniewicz ML; Hyland AJ; Cummings KM; Bansal-Travers M; Fong GT; O'Connor RJ
    Am J Prev Med; 2022 Oct; 63(4):611-618. PubMed ID: 35667923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of treatment on cardiovascular risk among smokeless tobacco users.
    Allen SS; Hatsukami D; Jensen J; Grillo M; Bliss R
    Prev Med; 1995 Jul; 24(4):357-62. PubMed ID: 7479625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of tobacco use and nicotine dependence among youth, United States, 2017-2018.
    Gomez Y; Creamer M; Trivers KF; Anic G; Morse AL; Reissig C; Agaku I
    Prev Med; 2020 Dec; 141():106284. PubMed ID: 33068604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cigarette users' interest in using or switching to electronic nicotine delivery systems for smokeless tobacco for harm reduction, cessation, or novelty: a cross-sectional survey of US adults.
    Berg CJ; Haardoerfer R; Escoffery C; Zheng P; Kegler M
    Nicotine Tob Res; 2015 Feb; 17(2):245-55. PubMed ID: 24951496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of electronic cigarette liquid flavors and nicotine concentration on subjective measures of abuse liability in young adult cigarette smokers.
    Cobb CO; Lopez AA; Soule EK; Yen MS; Rumsey H; Lester Scholtes R; Rudy AK; Lipato T; Guy M; Eissenberg T
    Drug Alcohol Depend; 2019 Oct; 203():27-34. PubMed ID: 31401532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential reduced exposure products (PREPs) for smokeless tobacco users: clinical evaluation methodology.
    Gray JN; Breland AB; Weaver M; Eissenberg T
    Nicotine Tob Res; 2008 Sep; 10(9):1441-8. PubMed ID: 19023835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Constituent Variations in Smokeless Tobacco Purchased in Mumbai, India.
    Stepanov I; Gupta PC; Parascandola M; Yershova K; Jain V; Dhumal G; Hatsukami DK
    Tob Regul Sci; 2017 Jul; 3(3):305-314. PubMed ID: 34734108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing Constituent Levels in Smokeless Tobacco Products: A New Approach to Engaging and Educating the Public.
    Borgida E; Loken B; Williams AL; Vitriol J; Stepanov I; Hatsukami D
    Nicotine Tob Res; 2015 Nov; 17(11):1354-61. PubMed ID: 25634934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of sensory and behavioral substitutes following an experimentally induced stressor among abstinent smokeless tobacco users.
    Prensky EH; Cohen LM; McChargue D; Gao W
    Am J Addict; 2010; 19(2):128-35. PubMed ID: 20163384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proposed definition of a smokeless tobacco user based on "potential" nicotine consumption.
    Schroeder KL; Chen MS; Iaderosa GR; Glover ED; Edmundson EW
    Addict Behav; 1988; 13(4):395-400. PubMed ID: 3239472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tobacco Product Use and Associated Factors Among Middle and High School Students - National Youth Tobacco Survey, United States, 2021.
    Gentzke AS; Wang TW; Cornelius M; Park-Lee E; Ren C; Sawdey MD; Cullen KA; Loretan C; Jamal A; Homa DM
    MMWR Surveill Summ; 2022 Mar; 71(5):1-29. PubMed ID: 35271557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Awareness, susceptibility, and use of oral nicotine pouches and comparative risk perceptions with smokeless tobacco among young adults in the United States.
    Morean ME; Bold KW; Davis DR; Kong G; Krishnan-Sarin S; Camenga DR
    PLoS One; 2023; 18(1):e0281235. PubMed ID: 36716297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative measurement of harmful and potentially harmful constituents, pH, and moisture content in 16 commercial smokeless tobacco products.
    Edwards SH; Hassink MD; Taylor KM; Vu AT
    Regul Toxicol Pharmacol; 2022 Aug; 133():105199. PubMed ID: 35662636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic Toxicity of Smokeless Tobacco Products in Mice.
    Malovichko MV; Zeller I; Krivokhizhina TV; Xie Z; Lorkiewicz P; Agarwal A; Wickramasinghe N; Sithu SD; Shah J; O'Toole T; Rai SN; Bhatnagar A; Conklin DJ; Srivastava S
    Nicotine Tob Res; 2019 Jan; 21(1):101-110. PubMed ID: 30085294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Method development and validation of dissolution testing for nicotine release from smokeless tobacco products using flow-through cell apparatus and UPLC-PDA.
    Miller JH; Danielson T; Pithawalla YB; Brown AP; Wilkinson C; Wagner K; Aldeek F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1141():122012. PubMed ID: 32065955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levels of nicotine in dust from homes of smokeless tobacco users.
    Whitehead TP; Metayer C; Park JS; Does M; Buffler PA; Rappaport SM
    Nicotine Tob Res; 2013 Dec; 15(12):2045-52. PubMed ID: 23884321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the abuse liability of three menthol Vuse Solo electronic cigarettes relative to combustible cigarettes and nicotine gum.
    Stiles MF; Campbell LR; Jin T; Graff DW; Fant RV; Henningfield JE
    Psychopharmacology (Berl); 2018 Jul; 235(7):2077-2086. PubMed ID: 29725702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exposure to nicotine and a tobacco-specific carcinogen increase with duration of use of smokeless tobacco.
    Hecht SS; Carmella SG; Edmonds A; Murphy SE; Stepanov I; Luo X; Hatsukami DK
    Tob Control; 2008 Apr; 17(2):128-31. PubMed ID: 18375734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of biomarkers of exposure and potential harm, and physiological and subjective health measures in exclusive users of nicotine pouches and current, former and never smokers.
    Azzopardi D; Haswell LE; Frosina J; McEwan M; Gale N; Thissen J; Meichanetzidis F; Hardie G
    Biomarkers; 2023 Feb; 28(1):118-129. PubMed ID: 36484137
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.